Pure Global

Incidence and Risk Factors of Low Anterior Resection Syndrome - Trial NCT06359730

Access comprehensive clinical trial information for NCT06359730 through Pure Global AI's free database. This phase not specified trial is sponsored by Zagazig University and is currently Completed. The study focuses on Colorectal Cancer. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06359730
Completed
other
Trial Details
ClinicalTrials.gov โ€ข NCT06359730
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Incidence and Risk Factors of Low Anterior Resection Syndrome
Incidence, Risk Factors Of Low Anterior Resection Syndrome And Validation Of LARS Score Among Egyptian Patients

Study Focus

Colorectal Cancer

LARS score questionnaire

Observational

other

Sponsor & Location

Zagazig University

Zagazig, Egypt

Timeline & Enrollment

N/A

Dec 01, 2017

Dec 01, 2022

120 participants

Primary Outcome

age,sex,medical disease,site of tumor,neoadjuvant therapy,site of anastmosis,type of meso-rectal excision,adjuvant therapy,type of surgery,type of anastmosis,LARS score

Summary

Sphincter sparing surgery is oftentimes associated with bowel dysfunction complaints, namely
 the low anterior resection syndrome (LARS). The LARS questionnaire is widely used to assess
 this syndrome.
 
 With advances in colorectal surgery, sparing sphincter surgeries are gaining popularity. But
 symptoms after surgery can affect the quality of life which has psychomotor effects. Low
 anterior resection syndrome score is a worldwide known questionnaire. Many countries have
 accredited validation and translation of this questionnaire, but to our knowledge; it is the
 first time in Egypt.

ICD-10 Classifications

Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon

Data Source

ClinicalTrials.gov

NCT06359730

Non-Device Trial